52
Views
4
CrossRef citations to date
0
Altmetric
Clinical Features

Diagnosis and Management of Nasal Congestion: The Role of Intranasal Corticosteroids

, MD
Pages 122-131 | Published online: 13 Mar 2015

References

  • . Bousquet J, Khaltaev N, Cruz AA, ; World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008;63( suppl 86):8–160
  • . National Academy on an Aging Society. Chronic Conditions: A Challenge for the 21st Century. Washington, DC: National Academy on an Aging Society; 2000
  • . American Academy of Allergy, Asthma and Immunology (AAAAI). The Allergy Report: Diseases of the Atopic Diathesis. Milwaukee, WI: AAAAI; 2000
  • . McCory DC, Williams JW, Dolor RJ, . Management of Allergic Rhinitis in the Working-Age Population. Agency for Healthcare Research and Quality. AHQR publication no. 03-E013; 2003
  • . Douglass JA, O'Hehir RE. 1. Diagnosis, treatment and prevention of allergic disease: the basics. Med J Aust. 2006;185(4):228–233
  • . Skoner DB. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108( suppl 1): S2–S8
  • . Carr V. Improving the management and quality of life of patients with allergic rhinitis. Prof Nurse. 2005;20(8):31–33
  • . Trangsrud AJ, Whitaker AL, Small RE. Intranasal corticosteroids for allergic rhinitis. Pharmacotherapy. 2002;22(11):1458–1467
  • . Pearlman DS. Pathophysiology of the inflammatory response. J Allergy Clin Immunol. 1999;104(4 pt 1):S132–S137
  • . Wachs M, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Observations on the pathogenesis of nasal priming. J Allergy Clin Immunol. 1989;84(4 pt 1):492–501
  • . Storms WW. Minimal persistent inflammation, an emerging concept in the nature and treatment of allergic rhinitis: the possible role of leukotrienes. Ann Allergy Asthma Immunol. 2003;91(2):131–140
  • . International Consensus Report on the Diagnosis and Management of Rhinitis. International Rhinitis Management Working Group. Allergy. 1994;19( 19 suppl):1–34
  • . Bousquet J, Neukirch F, Bousquet PJ, . Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol. 2006;117(1):158–162
  • . Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24(5):758–764
  • . Ciprandi G, Cirillo I, Vizzaccaro A, . Seasonal and perennial allergic rhinitis: is this classification adherent to real life? Allergy. 2005;60(7):882–887
  • . Wallace DV, Dykewicz MS, Bernstein DI, . The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122( 2 suppl):S1–S84
  • . Leynaert B, Neukirch C, Kony S, . Association between asthma and rhinitis according to atopic sensitization in a population-based study. J Allergy Clin Immunol. 2004;113(1):86–93
  • . Bugiani M, Carosso A, Migliore E, ; ISAYA (ECRHS Italy) Study Group. Allergic rhinitis and asthma comorbidity in a survey of young adults in Italy. Allergy. 2005;60(2):165–170
  • . Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol. 1997;99(2):S773–S780
  • . Shedden A. Impact of nasal congestion on quality of life and work productivity in allergic rhinitis: findings from a large online survey. Treat Respir Med. 2005;4(6):439–446
  • . Shedden A, Iezzoni D. Congestion and its impact on sleep in individuals with allergic rhinitis. Poster presented at: XXV Congress of the European Academy of Allergology and Clinical Immunology; June 10–14, 2006; Vienna, Austria
  • . Corey JP, Houser SM, Ng BA. Nasal congestion: a review of its etiology, evaluation, and treatment. Ear Nose Throat J. 2000;79(9): 690–693, 696, 698 passim.
  • . Benninger MS, Senior BA. The development of the Rhinosinusitis Disability Index. Arch Otolaryngol Head Neck Surg. 1997;123(11):1175–1179
  • . Kinney WC, Benninger MS. Assessment of quality of life among patients with sinonasal disease as determined by an Internet survey based on the Rhinosinusitis Disability Index. Ear Nose Throat J. 2007;86(8):482, 484–486.
  • . Piccirillo JF, Merritt MG, Richards ML. Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg. 2002;126(1):41–47
  • . Senior BA, Glaze C, Benninger MS. Use of the Rhinosinusitis Disability Index (RSDI) in rhinologic disease. Am J Rhinol. 2001;15(1):15–20
  • . Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol. 1999;104(2 pt 1):364–369
  • . Stull DE, Krouse J, Meltzer EO, . Development and validation of the Congestion Quantifier seven-item test (CQ7): a screening tool for nasal congestion. Value Health. 2007;10(6):457–465
  • . Stull D, Vernon MK, Canonica GW, Crespi S, Sandor D. Using the congestion quantifier seven-item test to assess change in patient symptoms and their impact. Allergy Asthma Proc. 2008;29(3):295–303
  • . Simons FE, Fraser TG, Reggin JD, Simons KJ. Individual differences in central nervous system response to antihistamines (H1-receptor antagonists). Ann Allergy Asthma Immunol. 1995;75(6 pt 1):507–514
  • . Simons FE, Fraser TG, Reggin JD, Roberts JR, Simons KJ. Adverse central nervous system effects of older antihistamines in children. Pediatr Allergy Immunol. 1996;7(1):22–27
  • . van Cauwenberge P, Bachert C, Passalacqua G, . Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy. 2000;55(2):116–134
  • . Benninger MS, Ahmad N, Marple BF. The safety of intranasal steroids. Otolaryngol Head Neck Surg. 2003;129(6):739–750
  • . Bachert C, El-Akkad T. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis. Ann Allergy Asthma Immunol. 2002;89(3):292–297
  • . Prenner BM, Schenkel E. Allergic rhinitis: treatment based on patient profiles. Am J Med. 2006;119(3):230–237
  • . Frølund L. Efficacy of an oral antihistamine, loratadine, as compared with a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis. Clin Otolaryngol Allied Sci. 1991;16(6):527–531
  • . Hughes K, Glass C, Ripchinski M, . Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy. 2003;58(5):380–385
  • . Bunnag C, Jareoncharsri P, Wong EC. A double-blind comparison of nasal budesonide and oral astemizole for the treatment of perennial rhinitis. Allergy. 1992;47(4 pt 1):313–317
  • . Stern MA, Wade AG, Ridout SM, Cambell LM. Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine. Ann Allergy Asthma Immunol. 1998;81(4):354–358
  • . Chervinsky P, Kunjibettu S, Miller DL, . Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2007; 99(1):69–76
  • . Fokkens WJ, Jogi R, Reinartz S, . Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy. 2007;62(9):1078–1084
  • . Kaiser HB, Naclerio RM, Given J, Toler TN, Ellsworth A, Philpot EE. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2007;119(6):1430–1437
  • . Martin BG, Ratner PH, Hampel FC, . Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents. Allergy Asthma Proc. 2007;28(2):216–225
  • . Nathan RA, Berger W, Yang W, . Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2008;100(5); 497–505
  • . Jordana G, Dolovich J, Briscoe MP, . Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol. 1996;97(2):588–595
  • . Bronsky EA, Dockhorn RJ, Meltzer EO, . Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 1996;97(4):915–921
  • . Darnell R, Pecoud A, Richards DH. A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen. Clin Exp Allergy. 1994;24(12):1144–1150
  • . Di Lorenzo G, Gervasi F, Drago A, . Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics. Clin Exp Allergy. 1999;29(10):1367–1377
  • . Ortolani C, Foresi A, Di Lorenzo G, . A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. The FLNCO2 Italian Study Group. Allergy. 1999;54(11):1173–1180
  • . Martin BG, Andrews CP, van Bavel JH, . Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. Ann Allergy Asthma Immunol. 2006;96(6):851–857
  • . Ratner PH, Howland WC 3rd, Arastu R, . Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast. Ann Allergy Asthma Immunol. 2003;90(5):536–542
  • . Saengpanich S, deTineo M, Naclerio RM, Baroody FM. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2003; 129(5):557–562
  • . Di Lorenzo G, Pacor ML, Pellitteri ME, . Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in monotherapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy. 2004;34(2):259–267
  • . Gawchik S, Goldstein S, Prenner B, John A. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray. Ann Allergy Asthma Immunol. 2003;90(4):416–421
  • . Mandl M, Nolop K, Lutsky BN. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194–079 Study Group. Ann Allergy Asthma Immunol. 1997;79:370–378
  • . Anolik R; Mometasone Furoate Nasal Spray with Loratadine Study Group. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2008;100(3):264–271
  • . Schoenwetter W, Lim J. Comparison of intranasal triamcinolone acetonide with oral loratadine for the treatment of patients with seasonal allergic rhinitis. Clin Ther. 1995;17(3):479–492
  • . Condemi J, Schulz R, Lim J. Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of life. Ann Allergy Asthma Immunol. 2000;84(5):533–538
  • . Gawchik SM, Lim J. Comparison of intranasal triamcinolone acetonide with oral loratadine in the treatment of seasonal ragweed-induced allergic rhinitis. Am J Manag Care. 1997;3(7):1052–1058
  • . Bernstein DI, Creticos PS, Busse WW, . Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. J Allergy Clin Immunol. 1996;97(3):749–755
  • . Benninger MS, Hadley JA, Osguthorpe JD, . Techniques of intranasal steroid use. Otolaryngol Head Neck Surg. 2004;130(1):5–24
  • . Holm AF, Fokkens WJ, Godthelp T, Mulder PG, Vroom TM, Rijntjes E. A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study. Clin Otolaryngol Allied Sci. 1998;23(1):69–73
  • . Minshall E, Ghaffar O, Cameron L, . Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg. 1998;118(5):648–654
  • . Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108( 5 suppl):S147–S334
  • . Dupclay L Jr, Doyle J. Assessment of intranasal corticosteroid use in allergic rhinitis: benefits, costs, and patient preferences. Am J Manag Care. 2002;8( 13 suppl):S335–S340
  • . Stokes M, Amorosi SL, Thompson D, Dupclay, L, Garcia J, Georges G. Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis. Otolaryngol Head Neck Surg. 2004; 131(3):225–231
  • . Blaiss MS. Efficacy, safety, and patient preference of inhaled nasal corticosteroids: a review of pertinent published data. Allergy Asthma Proc. 2001;22(6 suppl 1):S5–S10
  • . Meltzer EO, Bardelas J, Goldsobel A, Kaiser H. A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis. Treat Respir Med. 2005;4(4):289–296
  • . Meltzer EO, Stahlman JE, Leflein J, . Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study. Clin Ther. 2008;30(2):271–279
  • . Kaliner MA. Physician prescribing practices: the role of patient preference in the selection of nasal steroids. Allergy Asthma Proc. 2001; 22(6 suppl 1):S17–S22
  • . Benninger MS, Hadley JA, Osguthorpe JD, . Techniques of intranasal steroid use. Otolaryngol Head Neck Surg. 2004;130(1):5–24
  • . Benninger MS. Epistaxis and its relationship to handedness with use of intranasal steroid spray. Ear Nose Throat J. 2008;87(8):463–465

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.